FMDV 3A Antagonizes the Effect of ANXA1 to Positively Modulate Viral Replication
Open Access
- 23 May 2022
- journal article
- research article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 96 (12), e0031722
- https://doi.org/10.1128/jvi.00317-22
Abstract
The RIG-I-like receptor signaling pathway is crucial for producing type I interferon (IFN-I) against RNA viruses. The present study observed that viral infection increased annexin-A1 (ANXA1) expression, and ANXA1 then promoted RNA virus-induced IFN-I production. Compared to ANXA1 wild-type cells, ANXA1(-/-) knockout cells showed IFN-beta production decreasing after viral stimulation. RNA virus stimulation induced ANXA1 to regulate IFN-beta production through the TBK1-IRF3 axis but not through the NF-kappa B axis. ANXA1 also interacted with JAK1 and STAT1 to increase signal transduction induced by IFN-beta or IFN-gamma. We assessed the effect of ANXA1 on the replication of foot-and-mouth disease virus (FMDV) and found that ANXA1 inhibits FMDV replication dependent on IFN-I production. FMDV 3A plays critical roles in viral replication and host range. The results showed that FMDV 3A interacts with ANXA1 to inhibit its ability to promote IFN-beta production. We also demonstrated that FMDV 3A inhibits the formation of ANXA1-TBK1 complex. These results indicate that ANXA1 positively regulates RNA virus-stimulated IFN-beta production and FMDV 3A antagonizes ANXA1-promoted IFN-beta production to modulate viral replication. IMPORTANCE FMDV is a pathogen that causes one of the world's most destructive and highly contagious animal diseases. The FMDV 3A protein plays a critical role in viral replication and host range. Although 3A is one of the viral proteins that influences FMDV virulence, its underlying mechanisms remain unclear. ANXA1 is involved in immune activation against pathogens. The present study demonstrated that FMDV increases ANXA1 expression, while ANXA1 inhibits FMDV replication. The results also showed that ANXA1 promotes RNA virus-induced IFN-I production through the IRF3 axis at VISA and TBK1 levels. ANXA1 was also found to interact with JAK1 and STAT1 to strengthen signal transduction induced by IFN-beta and IFN-gamma. 3A interacted with ANXA1 to inhibit ANXA1-TBK1 complex formation, thereby antagonizing the inhibitory effect of ANXA1 on FMDV replication. This study helps to elucidate the mechanism underlying the effect of the 3A protein on FMDV replication. FMDV is a pathogen that causes one of the world's most destructive and highly contagious animal diseases. The FMDV 3A protein plays a critical role in viral replication and host range.Keywords
Funding Information
- National Key R&D Program of China (2021YFD1800300)
- Gansu province major project for science and technology development (21ZD3NA001)
- The development of Seneca virus vaccine project (LSY-2017-225)
- Technology major project of Gansu province (21ZD3NA001)
- Chinese Academy of Agricultural Science and Technology Innovation Project (CAAS-ZDRW202006, CAAS-ASTIP-2022-LVRI)
- The Science and Technology Innovation Project of CAAS (CAAS-ZDRW202006-03)
- The basic scientific research fund of LVRI (11610312020006)
- The basic scientific research fund of CAAS (Y2019YJ07-1)
- National Natural Science Foundation of China (31602037)
- National Natural Science Foundation of China (31941002)
This publication has 38 references indexed in Scilit:
- MAVS ubiquitination by the E3 ligase TRIM25 and degradation by the proteasome is involved in type I interferon production after activation of the antiviral RIG-I-like receptorsBMC Biology, 2012
- The Leader Proteinase of Foot-and-Mouth Disease Virus Negatively Regulates the Type I Interferon Pathway by Acting as a Viral DeubiquitinaseJournal of Virology, 2011
- Annexin-1 interacts with NEMO and RIP1 to constitutively activate IKK complex and NF-κB: implication in breast cancer metastasisOncogene, 2011
- Glycogen Synthase Kinase 3β Regulates IRF3 Transcription Factor-Mediated Antiviral Response via Activation of the Kinase TBK1Immunity, 2010
- Exploiting the Annexin A1 pathway for the development of novel anti‐inflammatory therapeuticsBritish Journal of Pharmacology, 2009
- ISG56 is a negative-feedback regulator of virus-triggered signaling and cellular antiviral responseProceedings of the National Academy of Sciences of the United States of America, 2009
- Annexin‐1‐deficient dendritic cells acquire a mature phenotype during differentiationThe FASEB Journal, 2008
- Post‐translational modification plays an essential role in the translocation of annexin A1 from the cytoplasm to the cell surfaceThe FASEB Journal, 2006
- Role of the amino-terminal domain in regulating interactions of annexin I with membranes: Effects of amino-terminal truncation and mutagenesis of the phosphorylation sitesBiochemistry, 1994
- Distinctive features of foot-and-mouth disease virus, a member of the picornavirus family; aspects of virus protein synthesis, protein processing and structureProgress in Biophysics and Molecular Biology, 1993